Jeanne Lenzer

Summary

Affiliation: Comenius University

Publications

  1. pmc Alteplase for stroke: money and optimistic claims buttress the "brain attack" campaign
    Jeanne Lenzer
    Oak Ridge Journalism, Ellenville, NY 12428, USA
    BMJ 324:723-9. 2002
  2. pmc Controversial stroke trial is under review following BMJ report
    Jeanne Lenzer
    BMJ 325:1131. 2002
  3. pmc Researcher received undisclosed payments of 300,000 dollars from Pfizer
    Jeanne Lenzer
    BMJ 333:1237. 2006
  4. pmc The importance of smelly feet and stinky cheese
    Jeanne Lenzer
    BMJ 333:771. 2006
  5. pmc Secret report surfaces showing that Pfizer was at fault in Nigerian drug tests
    Jeanne Lenzer
    BMJ 332:1233. 2006
  6. pmc Manufacturer admits increase in suicidal behaviour in patients taking paroxetine
    Jeanne Lenzer
    BMJ 332:1175. 2006
  7. pmc US agency wants to limit lawsuits against drug manufacturers
    Jeanne Lenzer
    BMJ 332:196. 2006
  8. pmc FDA investigates direct to consumer adverts
    Jeanne Lenzer
    BMJ 331:1102. 2005
  9. pmc What can we learn from medical whistleblowers?
    Jeanne Lenzer
    PLoS Med 2:e209. 2005
  10. pmc New law aims to distance the FDA from the drug industry
    Jeanne Lenzer
    BMJ 330:1106. 2005

Detail Information

Publications41

  1. pmc Alteplase for stroke: money and optimistic claims buttress the "brain attack" campaign
    Jeanne Lenzer
    Oak Ridge Journalism, Ellenville, NY 12428, USA
    BMJ 324:723-9. 2002
  2. pmc Controversial stroke trial is under review following BMJ report
    Jeanne Lenzer
    BMJ 325:1131. 2002
  3. pmc Researcher received undisclosed payments of 300,000 dollars from Pfizer
    Jeanne Lenzer
    BMJ 333:1237. 2006
  4. pmc The importance of smelly feet and stinky cheese
    Jeanne Lenzer
    BMJ 333:771. 2006
  5. pmc Secret report surfaces showing that Pfizer was at fault in Nigerian drug tests
    Jeanne Lenzer
    BMJ 332:1233. 2006
  6. pmc Manufacturer admits increase in suicidal behaviour in patients taking paroxetine
    Jeanne Lenzer
    BMJ 332:1175. 2006
  7. pmc US agency wants to limit lawsuits against drug manufacturers
    Jeanne Lenzer
    BMJ 332:196. 2006
  8. pmc FDA investigates direct to consumer adverts
    Jeanne Lenzer
    BMJ 331:1102. 2005
  9. pmc What can we learn from medical whistleblowers?
    Jeanne Lenzer
    PLoS Med 2:e209. 2005
  10. pmc New law aims to distance the FDA from the drug industry
    Jeanne Lenzer
    BMJ 330:1106. 2005
  11. pmc Drug company seeks to suppress internal memos
    Jeanne Lenzer
    BMJ 334:59. 2007
  12. pmc Nigerian judge orders arrests of Pfizer officials
    Jeanne Lenzer
    BMJ 336:11. 2008
  13. doi request reprint Truly independent research?
    Jeanne Lenzer
    BMJ 337:a1332. 2008
  14. doi request reprint Naming names: is there an (unbiased) doctor in the house?
    Jeanne Lenzer
    BMJ 337:a930. 2008
  15. pmc Review launched after Harvard psychiatrist failed to disclose industry funding
    Jeanne Lenzer
    BMJ 336:1327. 2008
  16. pmc Knowing me, knowing you
    Jeanne Lenzer
    BMJ 336:858-60. 2008
  17. pmc An untold story?
    Jeanne Lenzer
    BMJ 336:532-4. 2008
  18. pmc Unreported cholesterol drug data released by company
    Jeanne Lenzer
    BMJ 336:180-1. 2008
  19. pmc US Congress and European Research Council insist on open access to research results
    Jeanne Lenzer
    BMJ 336:176-7. 2008
  20. pmc Doctor takes "march of shame" to atone for drug company payments
    Jeanne Lenzer
    BMJ 336:20-1. 2008
  21. pmc Pfizer is asked to suspend sales of painkiller
    Jeanne Lenzer
    BMJ 330:862. 2005
  22. pmc FDA wins spoof award for its "collusion" with the drug industry
    Jeanne Lenzer
    BMJ 330:555. 2005
  23. pmc Eli Lilly defends itself against assertions in BMJ
    Jeanne Lenzer
    BMJ 330:161. 2005
  24. pmc Lay campaigners for prostate screening are funded by industry
    Jeanne Lenzer
    BMJ 326:680. 2003
  25. pmc Claim that smallpox vaccine protects against HIV is premature, say critics
    Jeanne Lenzer
    BMJ 327:699. 2003
  26. pmc US stroke legislation is revised after BMJ airs controversy
    Jeanne Lenzer
    BMJ 328:604. 2004
  27. pmc New Cochrane policy tightens limits on industry funding
    Jeanne Lenzer
    BMJ 328:976. 2004
  28. pmc Whistleblower removed from job for talking to the press
    Jeanne Lenzer
    BMJ 328:1153. 2004
  29. pmc Pfizer pleads guilty, but drug sales continue to soar
    Jeanne Lenzer
    BMJ 328:1217. 2004
  30. pmc Stockholders protest Pfizer's drug prices
    Jeanne Lenzer
    CMAJ 171:24. 2004
  31. pmc Whistleblower charges medical oversight bureau with corruption
    Jeanne Lenzer
    BMJ 329:69. 2004
  32. pmc FDA's counsel accused of being too close to drug industry
    Jeanne Lenzer
    BMJ 329:189. 2004
  33. pmc Scandals have eroded US public's confidence in drug industry
    Jeanne Lenzer
    BMJ 329:247. 2004
  34. pmc Whistleblower protection needed in Canada: advocates
    Jeanne Lenzer
    CMAJ 171:439. 2004
  35. pmc US consumer body calls for review of cholesterol guidelines
    Jeanne Lenzer
    BMJ 329:759. 2004
  36. pmc Pfizer criticised over delay in admitting drug's problems
    Jeanne Lenzer
    BMJ 329:935. 2004
  37. pmc Documents missing from a 10 year old murder case sent to the BMJ
    Jeanne Lenzer
    BMJ 329:1365. 2004
  38. pmc FDA to review "missing" drug company documents
    Jeanne Lenzer
    BMJ 330:7. 2005
  39. pmc Ties between regulators and business are attacked after politician takes top job in industry
    Jeanne Lenzer
    BMJ 330:60. 2005
  40. pmc US bill to shield drug companies from product liability
    Jeanne Lenzer
    BMJ 330:62. 2005
  41. pmc Whistleblower charges drug company with deceptive practices
    Jeanne Lenzer
    BMJ 326:620. 2003